European Pharmaceutical Review
JANUARY 30, 2024
The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.
Pharmaceutical Technology
DECEMBER 15, 2022
These factors combined affect the commercial viability of generic medicines, with some European drugmakers already warning that they may stop making cheap generic medicines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 13, 2022
Over the same period, total gross expenditures on brand and generic medicines nearly doubled – from $268 billion to $517 billion, according to the report. The argument has been made that reducing or eliminating rebates could result in lower list prices, and reduce out-of-pocket expenses for patients. ” says the report.
Hospital Pharmacy Europe
AUGUST 13, 2024
Shortages of medicines and medical devices are a matter of great concern to healthcare professionals, says Tiene Bauters PharmD PhD, Pharmacy Department, Ghent University Hospital, Belgium, as she offers her take on tackling this issue in Europe to maintain a strong medicines supply.
The Checkup by Singlecare
DECEMBER 10, 2024
This combination inhaler is also available as a generic medicine called fluticasone furoate and vilanterol , which are the names of the two medicines in the inhaler. Combination medications, like Symbicort , can help reduce COPD exacerbations that could lead to hospitalizations.
The Checkup by Singlecare
SEPTEMBER 7, 2023
The brand and generic medications are available in the following strengths: Lexapro and escitalopram tablets: 5 mg, 10 mg, 20 mg Escitalopram oral solution: 5 mg/5 mL The standard dosage is 10 mg once daily for adults and children. This ensures that generic drugs work the same as brand-name medications and have the same risks and benefits.
pharmaphorum
DECEMBER 15, 2020
Despite this, the role of generics can often be overlooked, however its performance during this crisis has demonstrated its crucial importance and ability to respond to a series of considerable challenges. The generics medicines sector can, too, play a substantial part in discovering new areas for licensed products to be used in.
Expert insights. Personalized for you.
98 
Let's personalize your content